Endometriosis Treatment Market Report

Global Endometriosis Treatment Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 11, 2022
  • PAGES：149
  • REPORT CODE：GMM809837
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Endometriosis Treatment market report explains the definition, types, applications, major countries, and major players of the Endometriosis Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Eli Lilly

    • Takeda Pharmaceutical

    • Neurocrine Biosciences

    • AstraZeneca

    • AbbVie

    • Bayer

    • Astellas Pharma

    • Pfizer

    • Meditrina Pharmaceuticals

    By Type:

    • Hormonal Contraceptives

    • Gonadotropin-releasing Hormone (Gn-RH) Agonists

    • Progestin Therapy

    • Aromatase Inhibitors

    By End-User:

    • Hospital

    • Clinic

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Endometriosis Treatment Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Endometriosis Treatment Outlook to 2028- Original Forecasts

    • 2.2 Endometriosis Treatment Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Endometriosis Treatment Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Endometriosis Treatment Market- Recent Developments

    • 6.1 Endometriosis Treatment Market News and Developments

    • 6.2 Endometriosis Treatment Market Deals Landscape

    7 Endometriosis Treatment Raw Materials and Cost Structure Analysis

    • 7.1 Endometriosis Treatment Key Raw Materials

    • 7.2 Endometriosis Treatment Price Trend of Key Raw Materials

    • 7.3 Endometriosis Treatment Key Suppliers of Raw Materials

    • 7.4 Endometriosis Treatment Market Concentration Rate of Raw Materials

    • 7.5 Endometriosis Treatment Cost Structure Analysis

      • 7.5.1 Endometriosis Treatment Raw Materials Analysis

      • 7.5.2 Endometriosis Treatment Labor Cost Analysis

      • 7.5.3 Endometriosis Treatment Manufacturing Expenses Analysis

    8 Global Endometriosis Treatment Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Endometriosis Treatment Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Endometriosis Treatment Export by Region (Top 10 Countries) (2017-2028)

    9 Global Endometriosis Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Endometriosis Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Hormonal Contraceptives Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Gonadotropin-releasing Hormone (Gn-RH) Agonists Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Progestin Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Aromatase Inhibitors Consumption and Growth Rate (2017-2022)

    • 9.2 Global Endometriosis Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Endometriosis Treatment Market Analysis and Outlook till 2022

    • 10.1 Global Endometriosis Treatment Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Endometriosis Treatment Consumption (2017-2022)

      • 10.2.2 Canada Endometriosis Treatment Consumption (2017-2022)

      • 10.2.3 Mexico Endometriosis Treatment Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Endometriosis Treatment Consumption (2017-2022)

      • 10.3.2 UK Endometriosis Treatment Consumption (2017-2022)

      • 10.3.3 Spain Endometriosis Treatment Consumption (2017-2022)

      • 10.3.4 Belgium Endometriosis Treatment Consumption (2017-2022)

      • 10.3.5 France Endometriosis Treatment Consumption (2017-2022)

      • 10.3.6 Italy Endometriosis Treatment Consumption (2017-2022)

      • 10.3.7 Denmark Endometriosis Treatment Consumption (2017-2022)

      • 10.3.8 Finland Endometriosis Treatment Consumption (2017-2022)

      • 10.3.9 Norway Endometriosis Treatment Consumption (2017-2022)

      • 10.3.10 Sweden Endometriosis Treatment Consumption (2017-2022)

      • 10.3.11 Poland Endometriosis Treatment Consumption (2017-2022)

      • 10.3.12 Russia Endometriosis Treatment Consumption (2017-2022)

      • 10.3.13 Turkey Endometriosis Treatment Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Endometriosis Treatment Consumption (2017-2022)

      • 10.4.2 Japan Endometriosis Treatment Consumption (2017-2022)

      • 10.4.3 India Endometriosis Treatment Consumption (2017-2022)

      • 10.4.4 South Korea Endometriosis Treatment Consumption (2017-2022)

      • 10.4.5 Pakistan Endometriosis Treatment Consumption (2017-2022)

      • 10.4.6 Bangladesh Endometriosis Treatment Consumption (2017-2022)

      • 10.4.7 Indonesia Endometriosis Treatment Consumption (2017-2022)

      • 10.4.8 Thailand Endometriosis Treatment Consumption (2017-2022)

      • 10.4.9 Singapore Endometriosis Treatment Consumption (2017-2022)

      • 10.4.10 Malaysia Endometriosis Treatment Consumption (2017-2022)

      • 10.4.11 Philippines Endometriosis Treatment Consumption (2017-2022)

      • 10.4.12 Vietnam Endometriosis Treatment Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Endometriosis Treatment Consumption (2017-2022)

      • 10.5.2 Colombia Endometriosis Treatment Consumption (2017-2022)

      • 10.5.3 Chile Endometriosis Treatment Consumption (2017-2022)

      • 10.5.4 Argentina Endometriosis Treatment Consumption (2017-2022)

      • 10.5.5 Venezuela Endometriosis Treatment Consumption (2017-2022)

      • 10.5.6 Peru Endometriosis Treatment Consumption (2017-2022)

      • 10.5.7 Puerto Rico Endometriosis Treatment Consumption (2017-2022)

      • 10.5.8 Ecuador Endometriosis Treatment Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Endometriosis Treatment Consumption (2017-2022)

      • 10.6.2 Kuwait Endometriosis Treatment Consumption (2017-2022)

      • 10.6.3 Oman Endometriosis Treatment Consumption (2017-2022)

      • 10.6.4 Qatar Endometriosis Treatment Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Endometriosis Treatment Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Endometriosis Treatment Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Endometriosis Treatment Consumption (2017-2022)

      • 10.7.2 South Africa Endometriosis Treatment Consumption (2017-2022)

      • 10.7.3 Egypt Endometriosis Treatment Consumption (2017-2022)

      • 10.7.4 Algeria Endometriosis Treatment Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Endometriosis Treatment Consumption (2017-2022)

      • 10.8.2 New Zealand Endometriosis Treatment Consumption (2017-2022)

    11 Global Endometriosis Treatment Competitive Analysis

    • 11.1 Eli Lilly

      • 11.1.1 Eli Lilly Company Details

      • 11.1.2 Eli Lilly Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Eli Lilly Endometriosis Treatment Main Business and Markets Served

      • 11.1.4 Eli Lilly Endometriosis Treatment Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Takeda Pharmaceutical

      • 11.2.1 Takeda Pharmaceutical Company Details

      • 11.2.2 Takeda Pharmaceutical Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Takeda Pharmaceutical Endometriosis Treatment Main Business and Markets Served

      • 11.2.4 Takeda Pharmaceutical Endometriosis Treatment Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Neurocrine Biosciences

      • 11.3.1 Neurocrine Biosciences Company Details

      • 11.3.2 Neurocrine Biosciences Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Neurocrine Biosciences Endometriosis Treatment Main Business and Markets Served

      • 11.3.4 Neurocrine Biosciences Endometriosis Treatment Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 AstraZeneca

      • 11.4.1 AstraZeneca Company Details

      • 11.4.2 AstraZeneca Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 AstraZeneca Endometriosis Treatment Main Business and Markets Served

      • 11.4.4 AstraZeneca Endometriosis Treatment Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 AbbVie

      • 11.5.1 AbbVie Company Details

      • 11.5.2 AbbVie Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 AbbVie Endometriosis Treatment Main Business and Markets Served

      • 11.5.4 AbbVie Endometriosis Treatment Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Bayer

      • 11.6.1 Bayer Company Details

      • 11.6.2 Bayer Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Bayer Endometriosis Treatment Main Business and Markets Served

      • 11.6.4 Bayer Endometriosis Treatment Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Astellas Pharma

      • 11.7.1 Astellas Pharma Company Details

      • 11.7.2 Astellas Pharma Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Astellas Pharma Endometriosis Treatment Main Business and Markets Served

      • 11.7.4 Astellas Pharma Endometriosis Treatment Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Pfizer

      • 11.8.1 Pfizer Company Details

      • 11.8.2 Pfizer Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Pfizer Endometriosis Treatment Main Business and Markets Served

      • 11.8.4 Pfizer Endometriosis Treatment Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Meditrina Pharmaceuticals

      • 11.9.1 Meditrina Pharmaceuticals Company Details

      • 11.9.2 Meditrina Pharmaceuticals Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Meditrina Pharmaceuticals Endometriosis Treatment Main Business and Markets Served

      • 11.9.4 Meditrina Pharmaceuticals Endometriosis Treatment Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Endometriosis Treatment Market Outlook by Types and Applications to 2028

    • 12.1 Global Endometriosis Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Hormonal Contraceptives Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Gonadotropin-releasing Hormone (Gn-RH) Agonists Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Progestin Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Aromatase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Endometriosis Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Endometriosis Treatment Market Analysis and Outlook to 2028

    • 13.1 Global Endometriosis Treatment Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.2.2 Canada Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Endometriosis Treatment Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.3.2 UK Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.3.3 Spain Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.3.5 France Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.3.6 Italy Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.3.8 Finland Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.3.9 Norway Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.3.11 Poland Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.3.12 Russia Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Endometriosis Treatment Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.4.2 Japan Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.4.3 India Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Endometriosis Treatment Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.5.3 Chile Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.5.6 Peru Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Endometriosis Treatment Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.6.3 Oman Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Endometriosis Treatment Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Endometriosis Treatment Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Endometriosis Treatment Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Endometriosis Treatment Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Endometriosis Treatment

    • Figure of Endometriosis Treatment Picture

    • Table Global Endometriosis Treatment Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Endometriosis Treatment Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Hormonal Contraceptives Consumption and Growth Rate (2017-2022)

    • Figure Global Gonadotropin-releasing Hormone (Gn-RH) Agonists Consumption and Growth Rate (2017-2022)

    • Figure Global Progestin Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Aromatase Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Endometriosis Treatment Consumption by Country (2017-2022)

    • Table North America Endometriosis Treatment Consumption by Country (2017-2022)

    • Figure United States Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Canada Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Mexico Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Endometriosis Treatment Consumption by Country (2017-2022)

    • Figure Germany Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure UK Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Spain Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Belgium Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure France Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Italy Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Denmark Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Finland Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Norway Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Sweden Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Poland Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Russia Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Turkey Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Table APAC Endometriosis Treatment Consumption by Country (2017-2022)

    • Figure China Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Thailand Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Singapore Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Philippines Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Table South America Endometriosis Treatment Consumption by Country (2017-2022)

    • Figure Brazil Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Colombia Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Chile Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Argentina Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Peru Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Table GCC Endometriosis Treatment Consumption by Country (2017-2022)

    • Figure Bahrain Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Oman Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Qatar Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Table Africa Endometriosis Treatment Consumption by Country (2017-2022)

    • Figure Nigeria Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Africa Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Egypt Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Algeria Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Table Oceania Endometriosis Treatment Consumption by Country (2017-2022)

    • Figure Australia Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Endometriosis Treatment Consumption and Growth Rate (2017-2022)

    • Table Eli Lilly Company Details

    • Table Eli Lilly Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Endometriosis Treatment Main Business and Markets Served

    • Table Eli Lilly Endometriosis Treatment Product Portfolio

    • Table Takeda Pharmaceutical Company Details

    • Table Takeda Pharmaceutical Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Endometriosis Treatment Main Business and Markets Served

    • Table Takeda Pharmaceutical Endometriosis Treatment Product Portfolio

    • Table Neurocrine Biosciences Company Details

    • Table Neurocrine Biosciences Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurocrine Biosciences Endometriosis Treatment Main Business and Markets Served

    • Table Neurocrine Biosciences Endometriosis Treatment Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Endometriosis Treatment Main Business and Markets Served

    • Table AstraZeneca Endometriosis Treatment Product Portfolio

    • Table AbbVie Company Details

    • Table AbbVie Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Endometriosis Treatment Main Business and Markets Served

    • Table AbbVie Endometriosis Treatment Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Endometriosis Treatment Main Business and Markets Served

    • Table Bayer Endometriosis Treatment Product Portfolio

    • Table Astellas Pharma Company Details

    • Table Astellas Pharma Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Endometriosis Treatment Main Business and Markets Served

    • Table Astellas Pharma Endometriosis Treatment Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Endometriosis Treatment Main Business and Markets Served

    • Table Pfizer Endometriosis Treatment Product Portfolio

    • Table Meditrina Pharmaceuticals Company Details

    • Table Meditrina Pharmaceuticals Endometriosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Meditrina Pharmaceuticals Endometriosis Treatment Main Business and Markets Served

    • Table Meditrina Pharmaceuticals Endometriosis Treatment Product Portfolio

    • Figure Global Hormonal Contraceptives Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gonadotropin-releasing Hormone (Gn-RH) Agonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Progestin Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Aromatase Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Endometriosis Treatment Consumption Forecast by Country (2022-2028)

    • Table North America Endometriosis Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Endometriosis Treatment Consumption Forecast by Country (2022-2028)

    • Figure Germany Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Endometriosis Treatment Consumption Forecast by Country (2022-2028)

    • Figure China Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Endometriosis Treatment Consumption Forecast by Country (2022-2028)

    • Figure Brazil Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Endometriosis Treatment Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Endometriosis Treatment Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Endometriosis Treatment Consumption Forecast by Country (2022-2028)

    • Figure Australia Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Endometriosis Treatment Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US